TrialInternational journal of hematology2025

A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes.

Hiroshi Kosugi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.